Seasonal fluctuation of drug-resistant malaria parasites: a sign of fitness cost

Trends in Parasitology

Volumn 25, Issue 8, 2009, Pages 351-352

  Babiker, Hamza A ^a,b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN;

ALLELE; HEALTH CARE COST; LETTER; MALARIA; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; SEASON;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PREVALENCE; PROTOZOAN PROTEINS; SEASONS;

EID: 68049119987     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2009.05.006     Document Type: Letter

References (17)

1. Carrara V.I., et al. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4 (2009) e4551
2. Andersson D.I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6 (2003) 452-456
3. Clyde D.F. Treatment of multi-drug resistant malaria. East Afr. Med. J. 44 (1967) 231-327
4. Kublin J.G., et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003) 1870-1875
5. Nosten F., et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356 (2000) 297-302
6. Schoepflin S., et al. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population. Malar J. 6 (2008) 78
7. Plowe C.V., et al. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am. J. Trop. Med. Hyg. 55 (1996) 467-471
8. Walliker D., et al. Fitness of drug-resistant malaria parasites. Acta Trop. 94 (2005) 251-259
9. Abdel-Muhsin A.M.A., et al. Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. J. Infect. Dis. 189 (2004) 1239-1244
10. Ord R., et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 196 (2007) 1613-1619
11. Babiker H.A., et al. Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 94 (2005) 260-268
12. Babiker H.A., et al. Impaired fitness of drug resistant malaria parasites: evidence and implication on drug-deployment policies. Expert Rev. Anti Infect. Ther. 7 (2009) 581-593
13. de Roode J.C., et al. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar. J. 3 (2004) 33
14. Wargo A.R., et al. Competitive release and facilitation of drug-resistance parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19914-19919
15. Kobbe R., et al. Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa. Trop. Med. Int. Health 11 (2006) 613-619
16. Zwetyenga J., et al. A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 375-380
17. Felger I., and Beck H.P. Fitness costs of resistance to antimalarial drugs. Trends Parasitol. 24 (2008) 331-333